Home
»
In the News
Back to News Listing
7/19/2011
Nabi Biopharmaceuticals announced that its experimental antismoking vaccine NicVAX did not meet its main goal in a late-stage test. The company said about 11 percent of patients who received a placebo shot were able to quit smoking, and patients who received NicVAX quit at a similar rate.
Source: Forbes
Back to News Listing